Abstract
52-year-old male. The patient had a stage IV renal carcinoma with bone metastases. He started first-line treatment with nivolumab (3 mg/kg) associated with ipilimumab (1 mg/kg). After two cycles of treatment, the patient reported hemorrhagic diarrhoea (7 to 10 stools daily), with visceral nociceptive abdominal pain of moderate intensity and oral intolerance.
MeSH terms
-
Adrenal Cortex Hormones / therapeutic use
-
Antineoplastic Combined Chemotherapy Protocols
-
Carcinoma, Renal Cell* / drug therapy
-
Carcinoma, Renal Cell* / pathology
-
Colitis* / chemically induced
-
Humans
-
Ipilimumab / adverse effects
-
Kidney Neoplasms* / drug therapy
-
Kidney Neoplasms* / pathology
-
Male
-
Melanoma* / pathology
-
Nivolumab / adverse effects
Substances
-
Adrenal Cortex Hormones
-
Ipilimumab
-
Nivolumab